Acadia Pharmaceuticals market cap ACAD

Share price times shares outstanding: what the whole company sells for, since 2011.

Acadia Pharmaceuticals is worth $3.4B at the close on Oct 23, 2026, at $19.73 a share.

That is down 8% over the last year and up 18% over five years.

Its highest close in our data was $8.9B in Nov 2020.

Market cap over time

Year	End of year	Low	High	Change
2026 so far	$3.4B	$3.3B	$5.1B	−27%
2025	$4.7B	$2.4B	$4.7B	+66%
2024	$2.8B	$2.4B	$5B	−45%
2023	$5.1B	$2.8B	$5.2B	+99%
2022	$2.6B	$2.3B	$4.3B	−31%
2021	$3.8B	$2.6B	$8.5B	−56%
2020	$8.5B	$5.2B	$8.9B	+25%
2019	$6.8B	$2.2B	$7.9B	+246%
2018	$2B	$1.6B	$4B	−48%
2017	$3.7B	$3.2B	$4.8B	+7%
2016	$3.5B	$1.8B	$4.5B	−3%
2015	$3.6B	$3B	$5B	+14%
2014	$3.2B	$1.7B	$3.3B	+38%
2013	$2.3B	$280.3M	$2.6B	+800%
2012	$255.4M	$60.7M	$294.4M	+348%
2011	$57M	$51.7M	$74.4M	n/a

Companies in Drug Manufacturers - General nearest Acadia Pharmaceuticals' size, closest first, today.

Company	Market cap
ACADAcadia Pharmaceuticals	$3.4B
OGNOrganon	$3.6B
LQDALiquidia	$3.8B
ARQTArcutis Biotherapeutics	$3.9B
INDVIndivior Pharmaceuticals	$4.1B
NRIXNurix Therapeutics	$2.8B
PBHPrestige Consumer Healthcare	$2.3B
HRMYHarmony Biosciences	$2.1B
KNSAKiniksa Pharmaceuticals International	$6B
LGNDLigand Pharmaceuticals	$6.1B
AMRXAmneal Pharmaceuticals	$6.5B
Peer median	$3.9B